FDA panel to consider osteoarthritis drug tanezumab

By SASHA PEZENIK, ABC News (NEW YORK) -- A crucial vote of Food and Drug Administration advisory committee members is set for Thursday afternoon, and they could eventually determine whether some of the 32 million Americans suffering from osteoarthritis pain may find a... Read More.

WHO panel advises against hydroxychloroquine to prevent COVID-19

BY: JULIA JACOBO, ABC NEWS (WASHINGTON) — A World Health Organization panel is now advising against the use of hydroxychloroquine, the controversial drug promoted heavily by the Trump administration, to treat patients infected with COVID-19. The international health agency announced Monday that a panel... Read More.